Evidence map›Paper›PMID 34043272›Full record

ArticleAngewandte Chemie (International ed. in English)2021

Infrared Based Saliva Screening Test for COVID-19.

Bayden R Wood, Kamila Kochan, Diana E Bedolla, Natalia Salazar-Quiroz, Samantha L Grimley, David Perez-Guaita, Matthew J Baker, Jitraporn Vongsvivut, Mark J Tobin, Keith R Bambery and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. IR-EcoSpectra: Exploring sustainableJournal of pharmaceutical analysis · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 6 countries.

Bayden R WoodCentre for Biospectroscopy and School of Chemistry, Monash University, Clayton Campus, 3800, Victoria, Australia.ORCID 0000-0003-3581-447X
Kamila KochanCentre for Biospectroscopy and School of Chemistry, Monash University, Clayton Campus, 3800, Victoria, Australia.ORCID 0000-0002-7248-8637
Diana E BedollaCentre for Biospectroscopy and School of Chemistry, Monash University, Clayton Campus, 3800, Victoria, Australia.ORCID 0000-0003-1902-1517
Natalia Salazar-QuirozDepartment of Microbiology and Immunology, University of Melbourne, Melbourne, Australia.ORCID 0000-0002-9749-8516
Samantha L GrimleyDepartment of Microbiology and Immunology, University of Melbourne, Melbourne, Australia.ORCID 0000-0002-5803-3222
David Perez-GuaitaCentre for Biospectroscopy and School of Chemistry, Monash University, Clayton Campus, 3800, Victoria, Australia.ORCID 0000-0002-2640-2927
Matthew J BakerDepartment of Pure and Applied Chemistry, University of Strathclyde, Technology and Innovation Centre Level 7, 99 George Street, Glasgow, G1 1RD, Scotland, UK.
Jitraporn VongsvivutANSTO - Australian Synchrotron, 800 Blackburn Road, Clayton, Victoria, 3168, Australia.ORCID 0000-0003-0699-3464
Mark J TobinANSTO - Australian Synchrotron, 800 Blackburn Road, Clayton, Victoria, 3168, Australia.ORCID 0000-0003-1862-0649
Keith R BamberyANSTO - Australian Synchrotron, 800 Blackburn Road, Clayton, Victoria, 3168, Australia.ORCID 0000-0002-8489-1749
Dale ChristensenANSTO - Australian Synchrotron, 800 Blackburn Road, Clayton, Victoria, 3168, Australia.
Shivani PasrichaDepartment of Microbiology and Immunology, University of Melbourne, Melbourne, Australia.ORCID 0000-0001-9681-1956
Anthony K EdenCentre for Biospectroscopy and School of Chemistry, Monash University, Clayton Campus, 3800, Victoria, Australia.
Aaron McleanCentre for Biospectroscopy and School of Chemistry, Monash University, Clayton Campus, 3800, Victoria, Australia.
Supti RoyCentre for Biospectroscopy and School of Chemistry, Monash University, Clayton Campus, 3800, Victoria, Australia.
Jason A RobertsVictorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia.
Julian DruceVictorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia.
Deborah A WilliamsonDepartment of Microbiology and Immunology, University of Melbourne, Melbourne, Australia.ORCID 0000-0001-7363-6665
Julie McAuleyDepartment of Microbiology and Immunology, University of Melbourne, Melbourne, Australia.
Mike CattonVictorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia.
Damian F J PurcellDepartment of Microbiology and Immunology, University of Melbourne, Melbourne, Australia.ORCID 0000-0002-4485-1726
Dale I GodfreyAustralian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Melbourne, Victoria, 3010, Australia.ORCID 0000-0002-3009-5472
Philip HeraudCentre for Biospectroscopy and School of Chemistry, Monash University, Clayton Campus, 3800, Victoria, Australia.
The University of Melbourne · AUAustralian Nuclear Science and Technology Organisation · AUMonash University · AUAustralian Research Council · AUVictorian Infectious Diseases Reference Laboratory · AUAREA Science Park · ITThe Royal Melbourne Hospital · AUUniversitat de València · ESUniversity of Strathclyde · GB

Funding

2019 Ramon y Cajal Programme RYC2019-026556-IAustralian Nuclear Science and Technology Organisation Proposal ID. 16460 and 16476Australian Research Council CE140100011Faculty of Science, Monash University Monash Green Chemical Futures Special ProjectNational Health and Medical Research Council of Australia 1117766
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in an unprecedented need for diagnostic testing that is critical in controlling the spread of COVID-19. We propose a portable infrared spectrometer with purpose-built transflection accessory for rapid point-of-care detection of COVID-19 markers in saliva. Initially, purified virion particles were characterized with Raman spectroscopy, synchrotron infrared (IR) and AFM-IR. A data set comprising 171 transflection infrared spectra from 29 subjects testing positive for SARS-CoV-2 by RT-qPCR and 28 testing negative, was modeled using Monte Carlo Double Cross Validation with 50 randomized test and model sets. The testing sensitivity was 93 % (27/29) with a specificity of 82 % (23/28) that included positive samples on the limit of detection for RT-qPCR. Herein, we demonstrate a proof-of-concept high throughput infrared COVID-19 test that is rapid, inexpensive, portable and utilizes sample self-collection thus minimizing the risk to healthcare workers and ideally suited to mass screening.

Indexed as

AnimalsChlorocebus aethiopsCohort StudiesCOVID-19COVID-19 TestingDiscriminant AnalysisHumansLeast-Squares AnalysisMonte Carlo MethodPoint-of-Care TestingProof of Concept StudySalivaSARS-CoV-2Sensitivity and SpecificitySpecimen HandlingSpectrophotometry, InfraredCOVID-19 diagnosticFourier transform infrared (FTIR) spectroscopyRaman spectroscopysalivaSARS-CoV-2

Identifiers

PMID34043272
PMCPMC8222893
OpenAlexW3164946615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.